주식/증권 📈 긍정적

Pfizer gains priority review for Talzenna/Xtandi combo in prostate cancer

Seeking Alpha - Market News 07/22/2026 09:27:06 PM 71회

원문 기사 보기

관련 뉴스

Amplify LQD Investment Grade 12% Target Income ETF declares $0.2327 dividend

Syrah Resources reports Q3 activities

Midday Pulse: S&P 500 top intraday losers

Nvidia-backed Cohere closes in on $5B funding round

뉴스 목록으로